Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Sea Weed (Ecklonia Cava Extract) on Postprandial Blood Glucose and Insulin Level on Pre-diabetic Patients: A Double-blind Randomized-controlled Trial

NCT04864860 is registered in ClinicalTrials.gov with King Saud University as lead sponsor.

NCT NCT04864860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04864860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Sea Weed (Ecklonia Cava Extract) on Postprandial Blood Glucose and Insulin Level on Pre-diabetic Patients: A Double-blind Randomized-controlled Trial
Lead sponsor
King Saud University
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2021
Completion date
December 30, 2021
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prediabetes